Press releases | WebDisclosure

Basculer en Français

10964	Companies
240045	Keywords
168790	Articles
129145	Press releases

Home
Press releases

PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region
Formycon AG partners with MS Pharma for commercializing FYB203, a biosimilar candidate to Eylea in the MENA region, strengthening biosimilar portfolio and local production

Formycon AG MS Pharma Biosimilar FYB203 Eylea
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

RENK Group AG starts into the new fiscal year with strong revenue growth – guidance confirmed
RENK Group AG reports strong revenue growth and confirms guidance for 2024 fiscal year. Quarter 1 results show €238 million revenue, order intake at €208 million, and €28 million adjusted EBIT

Revenue Growth Adjusted EBIT RENK Group AG Guidance Q1 Results
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

Informations privilégiées / Communiqué sur comptes, résultats
MaaT Pharma annonce le succès de son offre globale de 19,2 millions d'euros pour financer ses activités de R&D en biotechnologie clinique avancée, incluant des essais cliniques et le développement de son portefeuille thérapeutique

Essais Cliniques Offre Globale MaaT Pharma Biotechnologie Clinique Portefeuille Thérapeutique
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

Inside Information / News release on accounts, results
MaaT Pharma announces successful completion of 19.2 million euros Global Offering with new shares, aims to fund R&D activities, Phase 3 trials, and broaden pipeline

Biotechnology Fundraising Clinical Trials Global Offering MaaT Pharma
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

Informations privilégiées / Autres communiqués
Hospitex obtient un brevet international pour kit cytoinclusion BLOCKfast, produit phare utile en anatomie pathologique, ouvrant perspectives de développement commercial mondial

Hospitex Développement Commercial BLOCKfast Brevet International Diagnostic Cancer
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

Information financière trimestrielle / Information financière du premier trimestre
Vitura annonce des revenus locatifs de 10,9 millions d’euros au 1er trimestre 2024, avec des projets de repositionnement en cours. Taux d'occupation à 82%

Taux D'occupation Revenus Locatifs Résultats Trimestriels Vitura Projet De Repositionnement
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

Quarterly financial reporting / First quarter financial report
Vitura reports €10.9M rental income in Q1 2024, signs major leases, continues repositioning programs. Occupancy rate at 82%. Details on financing and upcoming events

Financing Rental Income Occupancy Rate Vitura Leasing Transactions
PRESS RELEASE

published on 05/15/2024 at 07:30, 2 years 3 months ago

Inside Information / Other news releases
Hospitex International obtains international patent for BLOCKfast cyto-inclusion kit, enhancing global cancer diagnosis solutions. Company offers innovative diagnostics solutions in cytology

Hospitex International BLOCKfast Cyto-inclusion Kit Global Commercial Development Cancer Diagnosis Solutions Cytology Diagnostics
PRESS RELEASE

published on 05/15/2024 at 07:29, 2 years 3 months ago

Supervisory Board and CFO Marc Hess jointly agree for him to leave Aareal Bank AG at the end of his contract
Aareal Bank CFO Marc Hess to leave at end of contract as Supervisory Board agrees. Successor to be decided. Hess praised for financial expertise and strategic leadership

CFO Supervisory Board Finance Aareal Bank Marc Hess
PRESS RELEASE

published on 05/15/2024 at 07:29, 2 years 3 months ago

Hapag-Lloyd with good start to 2024 in first quarter of year
Hapag-Lloyd reports good start to 2024 with refined 2024 earnings forecast amid stabilization of demand and rates in Q1

Hapag-Lloyd Q1 Results Shipping Industry 2024 Earnings Forecast Demand Stabilization

Accesswire

Published on 09/11/2026 at 13:00, 36 minutes ago

Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 9 hours 36 minutes ago

Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 15 hours 11 minutes ago

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 17:46, 19 hours 50 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 22 hours 16 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 13:27, 8 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 09/11/2026 at 13:24, 12 minutes ago

EQS-Adhoc: PAUL Tech AG: PAUL Tech AG seeks a two-year extension of the term of the EUR 35 million bond
Published on 09/11/2026 at 13:00, 36 minutes ago

Gastech 2026: The Global Energy Industry Arrives in Bangkok as Asia Drives the Next Chapter of Energy Growth
Published on 09/11/2026 at 11:45, 1 hour 50 minutes ago

Halfords Group PLC: Result of AGM
Published on 09/11/2026 at 11:43, 1 hour 53 minutes ago

Skyborn reaches Financial Close on the Gennaker offshore wind farm project

Les Echos

Published on 09/11/2026 at 07:00, 6 hours 36 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 6 hours 36 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 6 hours 36 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 6 hours 36 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 18 hours 6 minutes ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE